Target intelligence / Profile preview

Dispelling blood stasis

01

Overview

Dispelling blood stasis (known as Huoxue Huayu) is a traditional Chinese medicine (TCM) therapeutic principle rather than a single molecular target such as a specific protein or receptor. This pharmacological category describes agents and strategies used to improve microcirculation, reduce blood viscosity, and resolve pathological hematological obstructions [1]. In a modern biomedical context, the effects of 'stasis-dispelling' agents are mediated through diverse molecular targets including cyclooxygenase-1 (COX-1), thrombin, and various cell adhesion molecules [2]. These agents are primarily utilized in the management of cardiovascular and cerebrovascular diseases, where they help prevent thrombus formation and protect vascular endothelial function [3]. Active compounds found in herbs like Salvia miltiorrhiza and Ligusticum wallichii, such as tanshinones and ferulic acid, demonstrate potent antiplatelet and anti-inflammatory properties [4]. While clinically effective for circulatory disorders, the lack of a single defined target makes drug-drug interactions, particularly with Western anticoagulants, a significant safety consideration [5]. (Citations: [1] PMID: 28250428; [2] PMC6035313; [3] NIH/NCCIH TCM Overview; [4] PubChem Compound Summary; [5] PMID: 30121111).

Other names
Huoxue HuayuPromoting blood circulation and removing blood stasisBlood-activating and stasis-resolvingInvigorating blood and transforming stasisBSR
02

Mechanism of action

Modulation of multiple molecular pathways including the inhibition of platelet activation (via GP IIb/IIIa or P2Y12 receptors), reduction of blood viscosity, suppression of the coagulation cascade, and enhancement of the plasminogen system to promote fibrinolysis.

03

Biological functions

AnticoagulationFibrinolysisVasodilationAnti-inflammationAntiplatelet aggregationMicrocirculation improvementEndothelial protection
04

Disease associations

Cardiovascular diseaseIschemic strokeThrombosisMyocardial infarctionAngina pectorisEndometriosisChronic inflammationDiabetic nephropathy
05

Safety considerations

Risk of systemic hemorrhageSynergistic bleeding risk when combined with conventional anticoagulants like Warfarin or AspirinContraindicated in pregnancy (risk of uterine contraction or miscarriage)Potential for post-operative bleeding complications
06

Interacting drugs

Salvia miltiorrhiza (Dan Shen)

7 more in the full profile.

07

Biomarkers

D-dimerFibrinogen levelPlatelet aggregation rateProthrombin time (PT)Activated partial thromboplastin time (aPTT)Thrombin time (TT)Blood viscosity

Beyond the preview

Go deeper on Dispelling blood stasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dispelling blood stasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call